Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 6 Colorectal Neoplasms 5 Neoplasms 4 Stomach Neoplasms 3 Malnutrition 3 Lung Neoplasms 3 Diarrhea 3 Uterine Cervical Neoplasms 2 Mucositis 2 Inflammation 2 Enteritis 2 Chalazion 2 Carcinoma, Hepatocellular 2 Thyroid Neoplasms 1 Squamous Intraepithelial Lesions 1 Smoldering Multiple Myeloma 1 Radiation Injuries 1 Psychological Well-Being 1 Psoriasis Vulgaris 1 Polycystic Ovary Syndrome 1 Periampullary Carcinoma Nos 1 Pelvic Neoplasms 1 Pelvic Inflammatory Disease 1 Papillomavirus Infections 1 Ovarian Neoplasms 1 Neoplasms, Second Primary 1 Muscle Invasive Bladder Cancer (MIBC) 1 Multiple Myeloma 1 Motor Activity 1 Monoclonal Gammopathy of Undetermined Significance 1

Interventions

testosterone undecanoate 1 Valganciclovir 1 Therapeutic Touch 1 TES 1 Procalcitonin 1 Probiotics 1 Etanercept 1 Drug Evaluation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Fatigue Syndrome, Chronic × Probiotics × Clear all

NCT03773003 2025-05-29

IMPROFA

Universität des Saarlandes

Phase NA Recruiting

Fatigue Syndrome, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡